Hyperion DeFi (NASDAQ:HYPD) Price Target Raised to $8.45

Hyperion DeFi (NASDAQ:HYPDFree Report) had its target price lifted by Chardan Capital from $7.30 to $8.45 in a report released on Tuesday, MarketBeat.com reports. They currently have a buy rating on the stock.

HYPD has been the subject of several other reports. Zacks Research lowered Hyperion DeFi from a “hold” rating to a “strong sell” rating in a report on Wednesday, August 12th. Weiss Ratings raised shares of Hyperion DeFi from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, September 1st. Finally, Cantor Fitzgerald boosted their target price on shares of Hyperion DeFi from $6.60 to $7.10 and gave the stock an “overweight” rating in a research report on Thursday, August 13th. Two analysts have rated the stock with a Buy rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $9.82.

Get Our Latest Stock Analysis on HYPD

Hyperion DeFi Trading Down 2.2%

Shares of NASDAQ:HYPD opened at $3.59 on Tuesday. The firm has a fifty day moving average of $2.96 and a two-hundred day moving average of $3.29. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.06. Hyperion DeFi has a 12-month low of $2.34 and a 12-month high of $15.00. The firm has a market capitalization of $55.79 million, a P/E ratio of -0.55 and a beta of 2.53.

Hyperion DeFi (NASDAQ:HYPDGet Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported $0.92 earnings per share (EPS) for the quarter. The business had revenue of $0.36 million during the quarter. Hyperion DeFi had a negative return on equity of 11.62% and a net margin of 416.56%. On average, equities analysts expect that Hyperion DeFi will post 1.78 EPS for the current fiscal year.

Hedge Funds Weigh In On Hyperion DeFi

Several hedge funds and other institutional investors have recently added to or reduced their stakes in HYPD. Renaissance Technologies LLC acquired a new stake in shares of Hyperion DeFi in the fourth quarter worth $663,000. Redwood Wealth Management Group LLC lifted its position in Hyperion DeFi by 2.1% during the 1st quarter. Redwood Wealth Management Group LLC now owns 183,273 shares of the company’s stock worth $632,000 after acquiring an additional 3,690 shares during the last quarter. Jane Street Group LLC bought a new stake in Hyperion DeFi during the fourth quarter valued at about $493,000. Focus Partners Advisor Solutions LLC acquired a new stake in shares of Hyperion DeFi in the fourth quarter valued at about $221,000. Finally, Geode Capital Management LLC acquired a new stake in shares of Hyperion DeFi in the fourth quarter valued at about $214,000. Institutional investors and hedge funds own 25.84% of the company’s stock.

About Hyperion DeFi

(Get Free Report)

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.

Further Reading

Receive News & Ratings for Hyperion DeFi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperion DeFi and related companies with MarketBeat.com's FREE daily email newsletter.